President & Chief Scientific OfficerSteve Burton

Dr. Steve Burton has over 36 years of experience in company management, business development and the development of separation products and processes for the purification of biopharmaceuticals. He has been instrumental in the development of Astrea Bioseparations’ purification products and technologies which are used extensively for commercial manufacture of recombinant and plasma-derived protein therapeutics. Under Dr Burton’s direction, Astrea Bioseparations has grown to become a leading company in its field with a reputation for innovative, high quality/high performance chromatography adsorbents.

Dr. Burton gained his Ph.D. at the University of Cambridge and worked for Delta Biotechnology (now Albumedix) in the UK before joining Astrea Bioseparations in 1988 as a founding member and Research and Development Manager. He has held a variety of roles in the company before his appointment as Chief Scientific Officer in 2021.

Connect on